[go: up one dir, main page]

AR056014A1 - Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo - Google Patents

Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo

Info

Publication number
AR056014A1
AR056014A1 ARP060103362A ARP060103362A AR056014A1 AR 056014 A1 AR056014 A1 AR 056014A1 AR P060103362 A ARP060103362 A AR P060103362A AR P060103362 A ARP060103362 A AR P060103362A AR 056014 A1 AR056014 A1 AR 056014A1
Authority
AR
Argentina
Prior art keywords
compound
preparation
pharmaceutical composition
composition containing
aminocarbazol
Prior art date
Application number
ARP060103362A
Other languages
English (en)
Inventor
Maria Alessandra Alisi
Patricia Dragone
Guido Furlotti
Nicola Cazzolla
Vincenzo Russo
Giorgina Mangano
Isabella Coletta
Lorenzo Polenzani
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of AR056014A1 publication Critical patent/AR056014A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Composicion farmacéutica que contiene un compuesto de formula (1) o una sal farmacéuticamente aceptable del mismo. Procedimiento para la preparacion del compuesto mencionado anteriormente de formula (1) y las sales farmacéuticamente aceptables del mismo. Reivindicacion 1: Compuesto 3-aminocarbazol, caracterizado porque se selecciona de entre el grupo que comprende los compuestos de la Tabla 1 siguiente, y una sal farmacéuticamente aceptable de los mismos.
ARP060103362A 2005-08-03 2006-08-02 Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo AR056014A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001523A ITMI20051523A1 (it) 2005-08-03 2005-08-03 Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo

Publications (1)

Publication Number Publication Date
AR056014A1 true AR056014A1 (es) 2007-09-12

Family

ID=35501077

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103362A AR056014A1 (es) 2005-08-03 2006-08-02 Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo

Country Status (23)

Country Link
US (2) US7879900B2 (es)
EP (1) EP1910288B1 (es)
JP (1) JP5274252B2 (es)
KR (1) KR101278620B1 (es)
CN (1) CN101223139B (es)
AR (1) AR056014A1 (es)
AT (1) ATE471930T1 (es)
AU (1) AU2006275063B2 (es)
BR (1) BRPI0615158A8 (es)
CA (1) CA2609441C (es)
DE (1) DE602006015062D1 (es)
DK (1) DK1910288T3 (es)
EA (1) EA012786B1 (es)
ES (1) ES2345944T3 (es)
GE (1) GEP20104964B (es)
IL (1) IL187713A (es)
IT (1) ITMI20051523A1 (es)
MX (1) MX2008001551A (es)
PL (1) PL1910288T3 (es)
PT (1) PT1910288E (es)
SI (1) SI1910288T1 (es)
UA (1) UA93378C2 (es)
WO (1) WO2007014687A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2119705A1 (en) 2008-05-14 2009-11-18 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor
GB0812185D0 (en) 2008-07-03 2008-08-13 Dow Corning Polymers modified by silanes
GB0812186D0 (en) 2008-07-03 2008-08-13 Dow Corning Modified polyolefins
US10457639B2 (en) 2008-08-15 2019-10-29 Georgetown University Fluorescent regulators of RASSF1A expression and human cancer cell proliferation
GB201000128D0 (en) 2010-01-06 2010-02-24 Dow Corning Modified polymers
GB201000121D0 (en) 2010-01-06 2010-02-17 Dow Corning Modified polyolefins
GB201000120D0 (en) 2010-01-06 2010-02-17 Dow Corning Process for forming crosslinked and branched polymers
GB201000117D0 (en) 2010-01-06 2010-02-17 Dow Corning Organopolysiloxanes containing an unsaturated group
GB201006846D0 (en) 2010-04-23 2010-06-09 Glaxo Group Ltd Novel compounds
MX2010014124A (es) * 2010-12-17 2012-06-18 Gabriel Diaz Hernandez Solución antiséptica local de amplio espectro a base de hipodorito de sodio, bicarbonato de sodio, cloramfenicol, jabón y solución salina al 0.9%.
FR2972193B1 (fr) 2011-03-04 2014-07-04 Setup Performance Polyolefines modifiees, reticulables apres transformation, et procede de fabrication desdites polyolefines
US10376672B2 (en) 2013-03-15 2019-08-13 Auris Health, Inc. Catheter insertion system and method of fabrication
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
EP4125874A4 (en) * 2020-03-25 2024-05-01 SRI International LIPOXYGENASE INHIBITORS
CN112159345B (zh) * 2020-11-18 2023-08-25 湖北和昌新材料科技股份有限公司 N-乙基咔唑的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
WO2001007409A1 (en) 1999-07-23 2001-02-01 Astrazeneca Uk Limited Carbazole derivatives and their use as neuropeptide y5 receptor ligands
US6399631B1 (en) * 1999-07-23 2002-06-04 Pfizer Inc. Carbazole neuropeptide Y5 antagonists
AU769081B2 (en) * 1999-08-26 2004-01-15 Bristol-Myers Squibb Company NPY antagonists: spiroisoquinolinone derivatives
US20040067999A1 (en) 2000-12-22 2004-04-08 Block Michael Howard Carbazole derivatives and their use as neuropeptide y5 receptor ligands
DE10125961A1 (de) * 2001-05-29 2002-12-12 Boehringer Ingelheim Int Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden
CA2403307A1 (en) * 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
ITMI20050909A1 (it) 2005-05-19 2006-11-20 Acraf Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-

Also Published As

Publication number Publication date
EP1910288B1 (en) 2010-06-23
UA93378C2 (ru) 2011-02-10
US20080207727A1 (en) 2008-08-28
DK1910288T3 (da) 2010-10-11
JP2009502999A (ja) 2009-01-29
CA2609441C (en) 2013-09-03
JP5274252B2 (ja) 2013-08-28
EP1910288A1 (en) 2008-04-16
ITMI20051523A1 (it) 2007-02-04
MX2008001551A (es) 2008-04-22
ES2345944T3 (es) 2010-10-06
US8207214B2 (en) 2012-06-26
EA012786B1 (ru) 2009-12-30
IL187713A0 (en) 2008-08-07
CN101223139B (zh) 2010-11-17
WO2007014687A1 (en) 2007-02-08
ATE471930T1 (de) 2010-07-15
CN101223139A (zh) 2008-07-16
SI1910288T1 (sl) 2010-10-29
US20110046197A1 (en) 2011-02-24
US7879900B2 (en) 2011-02-01
IL187713A (en) 2011-09-27
BRPI0615158A8 (pt) 2018-03-06
PT1910288E (pt) 2010-08-18
AU2006275063B2 (en) 2012-03-08
BRPI0615158A2 (pt) 2011-05-03
GEP20104964B (en) 2010-04-26
PL1910288T3 (pl) 2010-11-30
EA200800502A1 (ru) 2008-06-30
KR101278620B1 (ko) 2013-06-25
CA2609441A1 (en) 2007-02-08
KR20080040691A (ko) 2008-05-08
DE602006015062D1 (de) 2010-08-05
AU2006275063A1 (en) 2007-02-08
HK1112916A1 (en) 2008-09-19

Similar Documents

Publication Publication Date Title
AR056873A1 (es) Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas
AR058901A1 (es) Compuestos derivados de hidantoina, utiles para el tratamiento de trastornos inflamatorios y composicion farmaceutica que los comprende
AR056014A1 (es) Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo
AR126914A1 (es) Inhibidores de ras novedosos
AR063096A1 (es) Pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina
AR106237A2 (es) Inhibidores heterocíclicos de la aspartil proteasa, sus sales farmacéuticamente aceptables
AR058780A1 (es) Imidazopirazinas como inhibidores de quinasas dependientes de ciclina
AR063097A1 (es) Pirazolopirimidinas[1,5-a] inhibidoras de quinasas dependientes de ciclina(cdk), composiciones farmaceuticas que las contienen y usos en el tratamiento de enfermedades proliferativas
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
AR088808A2 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
AR051405A1 (es) Compuestos de 2-carboxamido(3-amino)tiofeno
GT200600518A (es) Derivados de pirimidina
EA201000805A1 (ru) Бис-(сульфониламино)производные в терапии 066
ECSP055867A (es) Derivados de pirrolopirimidina
EA201001013A1 (ru) Бис(сульфониламино)производные для применения в терапии
CR20140368A (es) Derivados y composiciones de isoindol 4´-0-sustituidos, composiciones que las comprenden y metodos de uso de los mismos (divisional 11036)
AR058293A1 (es) Sales profarmacos y formulaciones de 1-[5-(4-amino-7-isopropil-7h-pirrolo[2,3-d]pirimidin-5-carbonil)-2-metoxi-fenil]-3-(2,4-dicloro-fenil)-urea
UY29087A1 (es) Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico
GT200600163A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
MX2020009530A (es) Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa.
MX9305947A (es) Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
UY29393A1 (es) Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
UY29085A1 (es) Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes
UY29370A1 (es) Derivados de tiazol, composiciones que lo contienen, procedimientos de preparación y aplicaciones

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee